-
Drugmaker agrees to pay more than $1 billion in Paxil settlements
Wednesday, July 28, 2010 � by jg
Bloomberg BusinessWeek: GlaxoSmithKline’s latest agreement involves more than 800 birth defect cases and brings the total it has agreed to pay in Paxil-related settlements to more than $2 billion.
-
A (small) victory for medical patients, and ethics
Thursday, June 24, 2010 � by scott
The University of Michigan Medical School has decided that it will no longer accept cash from drug companies to underwrite courses designed to keep doctors’ medical licenses current.
-
Maker of Paxil agrees to settle suits brought over birth defects
Wednesday, June 23, 2010 � by jg
The Legal Intelligencer: GlaxoSmithKline “has agreed to settle almost 200 cases in which plaintiffs allege the use of the antidepressant caused birth defects.”
-
Appeal of Prempro verdict denied by U.S. Supreme Court
Monday, June 21, 2010 � by jg
Bloomberg BusinessWeek: An Arkansas jury’s $2.7 million award to a woman who claimed her use of the hormone replacement drug led her to develop breast cancer was allowed to stand.
-
California’s Tort Wars: Election Day by the numbers
Friday, June 11, 2010 � by eric
Tort-war front groups for big oil, insurance and tobacco get walloped on election day.
-
Congressional committee chair says he hasn’t gotten a “straight story” from J&J
Friday, June 11, 2010 � by jg
New York Times: Edolphus Towns said Johnson & Johnson has held up an investigation his committee has undertaken into the company’s recent pediatric drug recalls.
-
Tort reform: Just an effort to shift responsibility
Wednesday, April 7, 2010 � by scott
Jim Marcinkowski, a lawyer and former congressional candidate in Michigan, argues that corporate and medical proponents of tort reform are really just trying to shift responsibility for their business actions to the consumers, or to government.